Worthington's Q3 2026 results show how a $2.3B bet on industrial tech pays. See how their pivot into sustainable energy drives growth.
·
·
6 min read
Pharma faces a 2026 margin squeeze. See how startups are cutting R&D costs by 25% and improving supply chains with new tech.
·
·
8 min read
NVCA warns startups: secure later-stage funding by extending runway 18-24 months. Learn how to meet stricter investor demands now.
·
·
4 min read
New manufacturing ventures face an 18% cost jump. See why commodity price volatility matters and what founders can do about it.
·
·
8 min read
CRISPR gene-editing in agriculture gets $1.2B funding. Learn how commercialization moves from lab to market, tackling crop disease by 2028.
·
·
9 min read
How will startups change drug delivery by 2026? AI, blockchain, and drones boost transparency, fight counterfeits, and expand access.
·
·
7 min read
See how energy startups are driving change in 2026. Learn about advanced nuclear, DAC, and grid tech securing a $500M contract. Why it matters now.
·
·
8 min read
CRISPR crops could reach $3B by 2030. See how gene editing fights climate change, boosts yields 15-20%, and improves food security.
·
·
8 min read
CSL Seqirus enters the UK flu market in 2027. Learn how this new player could diversify vaccine supply and boost national resilience against influenza.
·
·
9 min read
New startup tools use granular drug channel data to reshape pharma strategy. See how they improve market penetration and supply chains.
·
·
5 min read